NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
$32.23
-4.38%
-1.53
Notify me if price changes either direction
Buy NAMS stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
3.8B
Enterprise value
3.2B
Trailing PE
-13.015624880791
Forward PE
-19.756767
PEG Ratio
-0.054484011128891
Enterprise to EBITDA
-16.005
Enterprise to revenue
92.06
Price to book MRQ
5.179543
Price to sales TTM
107.203735
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
35.2M
EBITDA
-202720000
Diluted EPS TTM
-2.04
Total Cash (MRQ)
702.9M
Current ratio (MRQ)
12.567
Operating Cash Flow (TTM)
-144388992
NAMS trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
January 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
